AU2021901409A0 - Treatment for cytokine release syndrome - Google Patents

Treatment for cytokine release syndrome

Info

Publication number
AU2021901409A0
AU2021901409A0 AU2021901409A AU2021901409A AU2021901409A0 AU 2021901409 A0 AU2021901409 A0 AU 2021901409A0 AU 2021901409 A AU2021901409 A AU 2021901409A AU 2021901409 A AU2021901409 A AU 2021901409A AU 2021901409 A0 AU2021901409 A0 AU 2021901409A0
Authority
AU
Australia
Prior art keywords
treatment
cytokine release
release syndrome
syndrome
cytokine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
AU2021901409A
Inventor
Graham Kelly
Olivier Laczka
John Wilkinson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Noxopharm Ltd
Original Assignee
Noxopharm Ltd
Filing date
Publication date
Application filed by Noxopharm Ltd filed Critical Noxopharm Ltd
Publication of AU2021901409A0 publication Critical patent/AU2021901409A0/en
Pending legal-status Critical Current

Links

AU2021901409A 2021-05-12 Treatment for cytokine release syndrome Pending AU2021901409A0 (en)

Publications (1)

Publication Number Publication Date
AU2021901409A0 true AU2021901409A0 (en) 2021-05-27

Family

ID=

Similar Documents

Publication Publication Date Title
EP3846796A4 (en) Methods of treating cytokine release syndrome
IL297314A (en) Methods for treating cytokine release syndrome
EP3984851A4 (en) Elevating system
EP3758714A4 (en) Methods and compositions for treating angelman syndrome
EP3570940A4 (en) Use of pridopidine for the treatment of fragile x syndrome
IL277993A (en) Kit, composition and combination therapy for fragile x syndrome
EP3710016A4 (en) Methods and compositions for alleviating cytokine release syndrome
EP4017317A4 (en) Extension table
EP3934680A4 (en) Low-dose cytokine co-administered with irgd for treating cancer
EP3762416A4 (en) Compositions and methods for the treatment of macrophage activation syndrome
IL304502A (en) Compositions and methods for treating cytokine release syndrome
EP4017316A4 (en) Extension table
EP3989959A4 (en) Transdermal formulations
EP3970565A4 (en) Bed device
EP3768281A4 (en) Compositions and methods for t-cell and cytokine activation
EP3782625A4 (en) Agent for improving cytokine release syndrome, etc
EP3960241A4 (en) Therapeutic agent for flavivirus infection
EP4008696A4 (en) Surface treatment agent
EP4046683A4 (en) Mouthpiece-type treatment device
AU2021901409A0 (en) Treatment for cytokine release syndrome
EP3949900A4 (en) Angle adjustment stage device for dental technique
ZA202210315B (en) Peptide for the treatment of cytokine storm syndrome
EP4096783A4 (en) Compositions for hemorrhoid treatment
EP4180171A4 (en) Table device
EP3737703A4 (en) Treatment of fragile x syndrome